Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.89 USD | -1.83% | -4.37% | +17.03% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.03% | 735M | |
+18.94% | 125B | |
+14.05% | 108B | |
-4.50% | 24.57B | |
+3.09% | 22.82B | |
-10.44% | 18.19B | |
-41.48% | 16.54B | |
-12.28% | 16.5B | |
+2.99% | 13.39B | |
+27.39% | 11.1B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- WAVE Life Sciences Shares Surge After Q4 Beats Estimates